ERMA — Enorama Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK88.39m
- SEK86.29m
- SEK2.74m
Brief: Enorama Pharma Appoints Claes Eliasson As Interim CFO
Brief: Enorama Pharma Extends Loan Agreement With Ds Global Pte. Limited
Brief: Enorama Pharma Extends Period For Trading In Subscription Rights In Ongoing Rights Issue
Brief: Enorama Pharma Q4 Operating Loss Widens TO SEK 26.7 Mln
Brief: Enorama Pharma In Licence Negotiations With Habit Factory
Brief: Enorama Negotiates Termination Of Agreement With Premier Manufacturing
Brief: Enorama Pharma Resolves On Rights Issue Of SEK 35 Mln
Brief: Frida Bexelius Resigns As CFO Of Enorama Pharma
Brief: Enorama Pharma Q3 Oper Loss At SEK 4.5 Mln
Brief: Enorama Pharma Appoints Frida Bexelius As CFO
Brief: Enorama Pharma Explores Divestment Of Nicotine Replacement Therapy Chewing Gum Business
Brief: Enorama Q2 Net Sales SEK 5.6 Million
Brief: Enorama Pharma Signs Supply Agreement With Habit Factory In Sweden
Brief: Enorama Pharma Appoints Daniel Schröder As CEO
Brief: Enorama Pharma Q1 Operating Loss Widens To SEK 10 Million
Brief: Enorama Resolves on Rights Issue, Gets Proceeds Of About SEK 28.65 Mln
Brief: Enorama Pharma Q4 Net Sales Up At SEK 172,000
Brief: Enorama Pharma Unit Deal For Online Distribution In USA
Brief: Enorama Pharma Receives Lawsuit From Roccia